Ajanta Pharma Ltd.

BSE: 532331 | NSE: AJANTPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE031B01049 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Ajanta Pharma Ajanta Pharma Ltd. | BSE 2731.35 44.60 (1.66%) | NSE 2732.70 42.50 (1.58%) | Trade | Add

BSE Live

Dec 30, 11:58

2731.35 44.60 (1.66%)

Volume

AVERAGE VOLUME

5-Day

17,062

10-Day

9,430

30-Day

8,468

4,884

Prev. Close

2686.75
Open Price

2687.20

Bid Price (Qty.)
2728.65 (9)
Offer Price (Qty.)
2731.80 (3)

NSE Live

Dec 30, 11:58

2732.70 42.50 (1.58%)

Volume

AVERAGE VOLUME

5-Day

282,131

10-Day

163,775

30-Day

101,329

132,951

Prev. Close

2690.20
Open Price

2702.40

Bid Price (Qty.)
2730.30 (2)
Offer Price (Qty.)
2732.70 (13)

Financials

Print/Copy to Excel : Go

Balance Sheet of Ajanta Pharma (in Rs. Cr.)	Mar 15	Mar 14	Mar 13	Mar 12	Mar 11
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	17.68	17.67	11.80	11.80	11.80
Total Share Capital	17.68	17.67	11.80	11.80	11.80
Reserves and Surplus	768.65	518.65	344.48	260.04	203.75
Total Reserves and Surplus	768.65	518.65	344.48	260.04	203.75
Total Shareholders Funds	786.33	536.32	356.28	271.83	215.55
NON-CURRENT LIABILITIES
Long Term Borrowings	32.27	51.28	72.20	75.36	59.05
Deferred Tax Liabilities [Net]	15.16	22.98	23.65	17.09	10.92
Other Long Term Liabilities	2.50	2.50	2.50	2.50	2.50
Long Term Provisions	4.76	2.83	2.98	4.91	2.66
Total Non-Current Liabilities	54.69	79.59	101.33	99.86	75.13
CURRENT LIABILITIES
Short Term Borrowings	17.90	60.54	51.26	86.87	76.97
Trade Payables	108.12	110.90	130.04	105.92	67.59
Other Current Liabilities	54.51	49.81	16.81	42.22	29.46
Short Term Provisions	64.30	42.71	19.66	10.45	8.21
Total Current Liabilities	244.83	263.96	217.77	245.46	182.22
Total Capital And Liabilities	1,085.85	879.87	675.38	617.16	472.91
ASSETS
NON-CURRENT ASSETS
Tangible Assets	268.16	260.02	253.09	223.30	206.19
Intangible Assets	3.16	1.38	9.64	13.26	0.00
Capital Work-In-Progress	170.20	93.55	12.49	2.51	17.22
Other Assets	0.00	0.00	0.00	0.00	0.00
Fixed Assets	441.52	354.95	275.22	239.08	223.41
Non-Current Investments	57.16	23.84	18.86	17.05	17.05
Deferred Tax Assets [Net]	0.00	0.00	0.00	0.00	0.00
Long Term Loans And Advances	8.87	38.68	48.41	50.56	33.38
Other Non-Current Assets	5.27	8.75	7.09	1.28	3.32
Total Non-Current Assets	512.82	426.22	349.58	307.97	277.16
CURRENT ASSETS
Current Investments	19.46	55.00	0.00	0.00	0.00
Inventories	153.05	148.77	143.51	162.35	96.12
Trade Receivables	240.85	177.09	135.19	125.42	75.76
Cash And Cash Equivalents	105.69	29.08	25.11	5.08	9.31
Short Term Loans And Advances	45.04	43.09	21.32	15.61	14.53
OtherCurrentAssets	8.94	0.62	0.67	0.73	0.03
Total Current Assets	573.03	453.65	325.80	309.19	195.75
Total Assets	1,085.85	879.87	675.38	617.16	472.91
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	16.15	51.33	83.39	75.65	52.64
CIF VALUE OF IMPORTS
Raw Materials	49.65	30.00	39.30	34.42	31.51
Stores, Spares And Loose Tools	0.00	0.30	0.71	0.41	0.59
Trade/Other Goods	0.00	0.30	0.71	0.41	0.59
Capital Goods	14.96	29.88	12.36	4.71	2.97
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency	59.43	56.61	41.08	28.16	25.32
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency	0.10	0.37	0.13	0.02	0.01
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods	806.20	660.56	506.67	342.68	261.86
Other Earnings	43.23	29.01	23.17	12.10	8.05
BONUS DETAILS
Bonus Equity Share Capital	7.09	7.09	1.23	1.23	1.23
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	45.35	--	--	--	--
Non-Current Investments Unquoted Book Value	24.07	23.84	18.86	17.05	17.05
CURRENT INVESTMENTS
Current Investments Quoted Market Value	19.89	56.98	--	--	--
Current Investments Unquoted Book Value	--	--	--	--	--